SynthesisCancer immunology, immunotherapy : CII2023

The landscape of objective response rate of anti-PD-1/L1 monotherapy across 31 types of cancer: a system review and novel biomarker investigating.

Yize Mao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.